News on Telik from BioPortfolio.com http://www.BioPortfolio.com Consolidated Telik news from BioPortfolio.com Wed, 10 Feb 2010 02:47:37 GMT en Telik Announces Presentation and Webcast at 12th Annual BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995402&HITNO=0&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995402&THISHREF=http://c.moreover.com/click/here.pl%3fz2515645778%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995402&HITNO=0&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995402&THISHREF=http://c.moreover.com/click/here.pl%3fz2515645778%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Telik Announces Presentation and Webcast at 12th Annual BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995222&HITNO=1&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995222&THISHREF=http://c.moreover.com/click/here.pl%3fz2515541351%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995222&HITNO=1&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995222&THISHREF=http://c.moreover.com/click/here.pl%3fz2515541351%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Telik Announces Presentation and Webcast at 12th Annual BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994148&HITNO=2&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994148&THISHREF=http://c.moreover.com/click/here.pl%3fz2514895559%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994148&HITNO=2&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994148&THISHREF=http://c.moreover.com/click/here.pl%3fz2514895559%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Telik Announces Presentation and Webcast at 12th Annual BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994582&HITNO=3&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994582&THISHREF=http://c.moreover.com/click/here.pl%3fz2515125442%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994582&HITNO=3&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994582&THISHREF=http://c.moreover.com/click/here.pl%3fz2515125442%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Idenix Pharmaceuticals To Present at 12th Annual BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994322&HITNO=4&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994322&THISHREF=http://c.moreover.com/click/here.pl%3fz2514991151%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994322&HITNO=4&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994322&THISHREF=http://c.moreover.com/click/here.pl%3fz2514991151%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBreitbart.com: Telik Initiates Ezatiostat Hydrochloride Phase 1 Studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975537&HITNO=5&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975537&THISHREF=http://c.moreover.com/click/here.pl%3fz2504082565%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975537&HITNO=5&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975537&THISHREF=http://c.moreover.com/click/here.pl%3fz2504082565%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Business Review: Telik Announces Initiation of Phase 1 Clinical Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tabletshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960511&HITNO=6&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960511&THISHREF=http://c.moreover.com/click/here.pl%3fz2496272269%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960511&HITNO=6&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960511&THISHREF=http://c.moreover.com/click/here.pl%3fz2496272269%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Telik Announces Initiation of Phase 1 Clinical Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets in Combination With Lenalidomide (Revlihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960280&HITNO=7&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960280&THISHREF=http://c.moreover.com/click/here.pl%3fz2496138969%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960280&HITNO=7&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960280&THISHREF=http://c.moreover.com/click/here.pl%3fz2496138969%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Telik Announces Initiation of Phase 1 Clinical Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets in Combination With Lenalidomide (Revlimid(R)) in Patients With Myelodysplastic Syndrome (MDS)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960827&HITNO=8&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960827&THISHREF=http://c.moreover.com/click/here.pl%3fz2496447889%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960827&HITNO=8&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960827&THISHREF=http://c.moreover.com/click/here.pl%3fz2496447889%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Telik Announces Initiation of Phase 1 Clinical Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tabletshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960339&HITNO=9&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960339&THISHREF=http://c.moreover.com/click/here.pl%3fz2496160085%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960339&HITNO=9&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960339&THISHREF=http://c.moreover.com/click/here.pl%3fz2496160085%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: BiomedReports: News and FDA Updates for Spectrum (Nasdaq:SPPI), Telik (Nasdaq:TELK)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3964610&HITNO=10&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3964610&THISHREF=http://c.moreover.com/click/here.pl%3fz2498182107%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3964610&HITNO=10&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3964610&THISHREF=http://c.moreover.com/click/here.pl%3fz2498182107%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRBC Dain Rauscher: Telik initiates Phase I myelodysplastic syndrome trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962636&HITNO=11&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962636&THISHREF=http://c.moreover.com/click/here.pl%3fz2497387704%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962636&HITNO=11&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962636&THISHREF=http://c.moreover.com/click/here.pl%3fz2497387704%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: BiomedReports: News and FDA Updates for Spectrum (Nasdaq:SPPI), Telik (Nasdaq:TELK)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3965156&HITNO=12&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3965156&THISHREF=http://c.moreover.com/click/here.pl%3fz2498406957%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3965156&HITNO=12&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3965156&THISHREF=http://c.moreover.com/click/here.pl%3fz2498406957%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Zacks' Voice of the People Highlights opportunities with Telik, Heska, and Hollis-Eden Pharmaceuticalshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3918518&HITNO=13&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3918518&THISHREF=http://c.moreover.com/click/here.pl%3fz2472860287%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3918518&HITNO=13&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3918518&THISHREF=http://c.moreover.com/click/here.pl%3fz2472860287%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Zacks' Voice of the People Highlights opportunities with Telik, Heska, and Hollis-Eden Pharmaceuticalshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3917669&HITNO=14&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3917669&THISHREF=http://c.moreover.com/click/here.pl%3fz2472421699%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3917669&HITNO=14&MSIZE=22&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Telik&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3917669&THISHREF=http://c.moreover.com/click/here.pl%3fz2472421699%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: